Gino Kang

US Patent:

20110265825, Nov 3, 2011

Filed:

May 2, 2011

Appl. No.:

13/099324

Inventors:

Bobby E. Rogers - San Diego CA, US
Gino Kang - Irvine CA, US

Assignee:

Ivera Medical Corporation - San Diego CA

International Classification:

B08B 9/00
A61L 2/18
A61L 2/16

US Classification:

134 221, 134166 R

Abstract:

A cleaning device for a site of a medical implement is disclosed, as are methods for using such devices. The cleaning device can include a cap having an opening to an inner cavity, and the opening can be adapted to receive a site of the medical implement. The inner cavity can include a male luer protrusion that extends up from an inner wall toward the opening, and can be sized and adapted for insertion into a female luer when the cap is provided on the medical implement. The cleaning device can further include a cleaning material that contains a cleaning agent prior to receipt of the site of the medical implement, i.e. the cleaning material is pre-loaded with the cleaning agent. The cleaning material can be at least partially secured in the inner cavity and adapted to swab and clean the site with the cleaning agent. The cap can further include a friction-forming member for creating a friction-based fitting of the cap onto the site of the medical implement.

US Patent:

20120216359, Aug 30, 2012

Filed:

Feb 16, 2012

Appl. No.:

13/398736

Inventors:

Bobby E. Rogers - San Diego CA, US
Gino Kang - Irvine CA, US

Assignee:

Ivera Medical Corporation - San Diego CA

International Classification:

B08B 1/00

US Classification:

1510493

Abstract:

A cleaning system for medical implements includes a number of cleaning caps attached to a substrate. Each cleaning cap can be selectively and individually removed from the substrate, which, prior to such removal, acts as a seal to the opening of each cap. Each cap includes an inner cavity accessible through the opening. The inner cavity holds a cleaning material that contains a cleaning agent, which is held in the inner cavity by the seal provided by the substrate. Upon removal, the cap can be placed on a site of a medical implement to clean the site by contact with the cleaning material and cleaning agent.

US Patent:

6482188, Nov 19, 2002

Filed:

Dec 17, 2001

Appl. No.:

10/023195

Inventors:

Bobby E. Rogers - San Diego CA
Kevin S. Nason - Menlo Park CA
Gino Kang - Newport Beach CA

Assignee:

Mission Medical Devices, Inc. - San Diego CA

International Classification:

A61M 500

US Classification:

604249, 2511496

Abstract:

An injection valve includes a housing having an inlet, an outlet, and a fluid channel extending between the inlet and the outlet. A piston is slidable within a bore of the housing between a first position wherein the piston is relatively far from the closed end and a second position wherein the piston is relatively near to the closed end. A biasing spring biases the piston toward the first position. The piston closes and seals the inlet when the piston is in the first position and allows fluid to pass from the inlet to the fluid channel to the outlet when the piston is in the second position. A piston seal is formed between the piston and a wall of the bore, dividing the bore into a unsealed chamber and a sealed chamber adjacent to the closed end. There is no vent between the sealed chamber and an exterior of the housing. Pressure differences between the unsealed chamber and the sealed chamber that adversely affect performance may be minimized by providing a deformable membrane or a gas accumulator communicating with the sealed chamber, or providing an initial pressure differential wherein a gas pressure within the sealed chamber is less than a gas pressure within the unsealed chamber, when the piston is in its first position.

US Patent:

20230116910, Apr 13, 2023

Filed:

Apr 26, 2022

Appl. No.:

17/730118

Inventors:

- San Diego CA, US
Gino KANG - Irvine CA, US
David Karl STROUP - San Diego CA, US
Jonas Dean COCHRAN - Santee CA, US
Arthur DEPTALA - Santee CA, US
John DETLOFF - San Diego CA, US
Lonnie POGUE - San Diego CA, US
Brian MACOWSKI - San Diego CA, US

International Classification:

A61B 5/15
A61B 5/153
A61B 5/154

Abstract:

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.

US Patent:

20210145336, May 20, 2021

Filed:

Nov 10, 2020

Appl. No.:

17/094692

Inventors:

- San Diego CA, US
Gino KANG - Irvine CA, US
David Karl STROUP - San Diego CA, US
Jonas Dean COCHRAN - Santee CA, US
Arthur DEPTALA - Santee CA, US
John DETLOFF - San Diego CA, US
Lonnie POGUE - San Diego CA, US
Brian MACOWSKI - San Diego CA, US

International Classification:

A61B 5/15
A61B 5/153

Abstract:

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.

US Patent:

20190159711, May 30, 2019

Filed:

Dec 4, 2018

Appl. No.:

16/208559

Inventors:

- San Diego CA, US
Gino Kang - Irvine CA, US
John Detloff - San Diego CA, US

International Classification:

A61B 5/15
A61B 5/153
A61M 39/04
A61M 39/06
A61B 5/154

Abstract:

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.

US Patent:

20180289304, Oct 11, 2018

Filed:

May 31, 2018

Appl. No.:

15/994559

Inventors:

- San Diego CA, US
Gino Kang - Irvine CA, US
John Detloff - San Diego CA, US

Assignee:

KURIN, INC. - San Diego CA

International Classification:

A61B 5/15
A61B 5/153
A61M 39/06
A61M 39/04
A61B 5/154
A61M 39/02

Abstract:

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.

US Patent:

20180271425, Sep 27, 2018

Filed:

Feb 9, 2018

Appl. No.:

15/893518

Inventors:

- San Diego CA, US
Gino KANG - San Diego CA, US
David Karl STROUP - San Diego CA, US
Jonas Dean COCHRAN - Santee CA, US
Arthur DEPTALA - Santee CA, US
John DETLOFF - San Diego CA, US
Lonnie POGUE - San Diego CA, US
Brian MACOWSKI - San Diego CA, US
Chad GARRETT - San Diego CA, US

Assignee:

Kurin, Inc. - San Diego CA

International Classification:

A61B 5/15

Abstract:

Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.